SEC Company Response from PROTHENA CORP PUBLIC LTD (PRTA) — Jun 18, 2019
PROTHENA CORP PUBLIC LTD CO
Date: June 18, 2019 · CIK: 0001559053 · Accession: 0001193125-19-175169
AI Filing Summary & Sentiment
File numbers found in text: 001-35676
Referenced dates: May 29, 2019
Show Raw Text
CORRESP 1 filename1.htm CORRESP Prothena Corporation plc 77 Sir John Rogerson’s Quay, Block C Grand Canal Docklands Dublin 2, D02 T804, Ireland June 18, 2019 VIA EDGAR TRANSMISSION U.S. Securities and Exchange Commission Division of Corporation Finance Office of Healthcare & Insurance 100 F Street, N.E. Washington, DC 20549 Attention: Frank Wyman Tabatha McCullom Re: Prothena Corporation plc Form 10-K for the Year Ended December 31, 2017 Filed February 26, 2018 Form 10-Q for the Quarterly Period Ended September 30, 2018 Filed November 6, 2018 File No. 001-35676 Ladies and Gentlemen: This letter is to confirm the receipt of your letter dated May 29, 2019 (the “SEC Comment Letter”) regarding the Annual Report on Form 10-K for the year ended December 31, 2017 and the Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2018 of Prothena Corporation plc (the “Company”). The Company plans to provide you with a response to the SEC Comment Letter on or before June 26, 2019. If you have any questions regarding the foregoing, please call John C. Williams of Latham & Watkins LLP at (650) 470-4887 or the undersigned at (650) 615-2113. Very truly yours, /s/ A. W. Homan A. W. Homan Chief Legal Officer and Company Secretary cc: Tran B. Nguyen Karin Walker Kathleen Wells